PLHCF Stock Analysis
PL
Uncovered
Plant Health Care PLC is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Plant Health Care Plc engages in the provision biological products. The company is headquartered in Holly Springs, North Carolina and currently employs 46 full-time employees. The company went IPO on 2004-07-06. The firm is focused on improving crop performance by activating a growth response and bolstering plant defense mechanisms against both abiotic and biotic stresses. Its segments include Americas, Mexico, and Rest of World. Its biological products help growers to protect their crops from stress and diseases, and to produce quality fruit and vegetables. Its commercial business is driven by sales of Harpin αβ, a recombinant protein which acts as a bio stimulant, promoting the yield and quality of crops. Its Saori promotes growth of soybeans and helps them fight disease. Plant Response Elicitor technology (PREtec) is its technology platform for developing new products. PHC279 is a peptide derived from the Innatus 3G family within the PREtec platform. PHC949 is a peptide developed from the T-Rex 3G family of PREtec platform. The firm also distributes third-party biological products.